Usually, MLH1 methylation is considered a somatic epigenetic mechanism that characterizes sporadic cancers, and it is used in the diagnostic flow chart based on universal tumor screening for mismatch repair defects to exclude LS [5,6]. This evidence concerns the gene MLH1 and neoplasm.